|
1
|
Ferlay J, Ervik M, Lam F, Colombet M, Mery
L, Piñeros M, Znaor A, Soerjomataram I and Bray F: global Cancer
Observatory: Cancer Today. IARC; Lyon: 2018, https://gco.iarc.fr/today.
Accessed March 8, 2019.
|
|
2
|
Kwapisz D: Cyclin-dependent kinase 4/6
inhibitors in breast cancer: Palbociclib, ribociclib, and
abemaciclib. Breast Cancer Res Treat. 166:41–54. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Woodcock CC, Huang Y, Woodcock SR,
Salvatore SR, Singh B, Golin-Bisello F, Davidson NE, Neumann CA,
Freeman BA and Wendell SG: Nitro-fatty acid inhibition of triple
negative breast cancer cell viability, migration, invasion and
tumor growth. J Biol Chem. 293:1120–1137. 2018. View Article : Google Scholar
|
|
4
|
Cocquerelle C, Mascrez B, Hétuin D and
Bailleul B: Mis-splicing yields circular RNA molecules. FASEB J.
7:155–160. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qu S, Yang X, Li X, Wang J, Gao Y, Shang
R, Sun W, Dou K and Li H: Circular RNA: A new star of noncoding
RNAs. Cancer Lett. 365:141–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meng X, Hu D, Zhang P, Chen Q and Chen M:
CircFunBase: A database for functional circular RNAs. Database
(Oxford) 2019. baz0032019.
|
|
8
|
Zhang Y, Yang L and Chen LL:
Characterization of circular RNAs. Methods Mol Biol. 1402:215–227.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:3843882013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hansen TB, Wiklund ED, Bramsen JB,
Villadsen SB, Statham AL, Clark SJ and Kjems J: miRNA-dependent
gene silencing involving Ago2-mediated cleavage of a circular
antisense RNA. EMBO J. 30:4414–4422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xin Z, Ma Q, Ren S, Wang G and Li F: The
understanding of circular RNAs as special triggers in
carcinogenesis. Brief Funct Genomics. 16:80–86. 2017.
|
|
12
|
Rybak‑Wolf A, Stottmeister C, Glažar P,
Jens M, Pino N, Giusti S, Hanan M, Behm M, Bartok O, Ashwal-Fluss
R, et al: Circular RNAs in the mammalian brain are highly abundant,
conserved, and dynamically expressed. Mol Cell. 58:870–885. 2015.
View Article : Google Scholar
|
|
13
|
Meng X, Zhu Y, Tao L, Zhao S and Qiu S:
miR-590-3p mediates melatonin-induced cell apoptosis by targeting
septin 7 in the human osteoblast cell line hFOB 1.19. Mol Med Rep.
17:7202–7208. 2018.PubMed/NCBI
|
|
14
|
Tang W, Ji M, He G, Yang L, Niu Z, Jian M,
Wei Y, Ren L and Xu J: Silencing CDR1as inhibits colorectal cancer
progression through regulating microRNA-7. Onco Targets Ther.
10:2045–2056. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Buglioni S, Vici P, Sergi D, Pizzuti L, Di
Lauro L, Antoniani B, Sperati F, Terrenato I, Carosi M, Gamucci T,
et al: Analysis of the hippo transducers TAZ and YAP in cervical
cancer and its microenvironment. Oncoimmunology. 5:e11601872016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Royer C, Koch S, Qin X, Zak J, Buti L,
Dudziec E, Zhong S, Ratnayaka I, Srinivas S and Lu X: ASPP2 links
the apical lateral polarity complex to the regulation of YAP
activity in epithelial cells. PLos One. 9:e1113842014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou X, Su J, Feng S, Wang L, Yin X, Yan J
and Wang Z: Antitumor activity of curcumin is involved in
down-regulation of YAP/TAZ expression in pancreatic cancer cells.
Oncotarget. 7:79076–79088. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi P, Feng J and Chen C: Hippo pathway in
mammary gland development and breast cancer. Acta Biochim Biophys
Sin (Shanghai). 47:53–59. 2015. View Article : Google Scholar
|
|
19
|
Plouffe SW, Hong AW and Guan KL: Disease
implications of the Hippo/YAP pathway. Trends Mol Med. 21:212–222.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bartucci M, Dattilo R, Moriconi C,
Pagliuca A, Mottolese M, Federici G, Benedetto AD, Todaro M, Stassi
G, Sperati F, et al: TAZ is required for metastatic activity and
chemoresistance of breast cancer stem cells. Oncogene. 34:681–690.
2015. View Article : Google Scholar
|
|
21
|
Cordenonsi M, Zanconato F, Azzolin L,
Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR,
Poletti A, et al: The Hippo transducer TAZ confers cancer stem
cell-related traits on breast cancer cells. Cell. 147:759–772.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Passaniti A, Brusgard JL, Qiao Y, Sudol M
and Finch-Edmondson M: Roles of RUNX in Hippo pathway signaling.
Adv Exp Med Biol. 962:435–448. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42(Database Issue): D92–D97. 2014. View Article : Google Scholar
|
|
25
|
Glažar P, Papavasileiou P and Rajewsky N:
circBase: A database for circular RNAs. RNA. 20:1666–1670. 2014.
View Article : Google Scholar
|
|
26
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41(Database Issue):
D991–D995. 2013. View Article : Google Scholar
|
|
27
|
Lappalainen I, Almeida-King J, Kumanduri
V, Senf A, Spalding JD, Ur-Rehman S, Saunders G, Kandasamy J,
Caccamo M, Leinonen R, et al: The European Genome-phenome Archive
of human data consented for biomedical research. Nat Genet.
47:692–695. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The Cancer Genome Atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.
|
|
29
|
Lánczky A, Nagy Á, Bottai G, Munkácsy G,
Szabó A, Santarpia L and Győrffy B: miRpower: A web‑tool to
validate survival‑associated miRNAs utilizing expression data from
2178 breast cancer patients. Breast Cancer Res Treat. 160:439–446.
2016. View Article : Google Scholar
|
|
30
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar :
|
|
31
|
Cowell JK, LaDuca J, Rossi MR, Burkhardt
T, Nowak NJ and Matsui S: Molecular characterization of the t(3;9)
associated with immortalization in the MCF10A cell line. Cancer
Genet Cytogenet. 163:23–29. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Beatty A, Fink LS, Singh T, Strigun A,
Peter E, Ferrer CM, Nicolas E, Cai KQ, Moran TP, Reginato MJ, et
al: Metabolite profiling reveals the glutathione biosynthetic
pathway as a therapeutic target in triple-negative breast cancer.
Mol Cancer Ther. 17:264–275. 2018. View Article : Google Scholar
|
|
34
|
Chen LL, Zhang ZJ, Yi ZB and Li JJ:
MicroRNA-211-5p suppresses tumour cell proliferation, invasion,
migration and metastasis in triple-negative breast cancer by
directly targeting SETBP1. Br J Cancer. 117:78–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Verduci L, Strano S, Yarden Y and Blandino
G: The circ RNA-micro RNA code: Emerging implications for cancer
diagnosis and treatment. Mol Oncol. 13:669–680. 2019.PubMed/NCBI
|
|
36
|
Hosseinahli N, Aghapour M, Duijf PH and
Baradaran B: Treating cancer with microRNA replacement therapy: A
literature review. J Cell Physiol. 233:5574–5588. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shah MY, Ferrajoli A, Sood AK,
Lopez-Berestein G and Calin GA: microRNA therapeutics in cancer-an
emerging concept. EBioMedicine. 12:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu Y, Liang H and Jiang X: MiR-1297
promotes apoptosis and inhibits the proliferation and invasion of
hepatocellular carcinoma cells by targeting HMGA2. Int J Mol Med.
36:1345–1352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li J, Gao J, Tian W, Li Y and Zhang J:
Long non-coding RNA MALAT1 drives gastric cancer progression by
regulating HMGB2 modulating the miR-1297. Cancer Cell Int.
17:442017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bu W and Luo T: miR-1297 promotes cell
proliferation of non-small cell lung cancer cells: Involving in
PTEN/Akt/Skp2 signaling pathway. DNA Cell Biol. 36:976–982. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li X, Wang HL, Peng X, Zhou HF and Wang X:
miR-1297 mediates PTEN expression and contributes to cell
progression in LSCC. Biochem Biophys Res Commun. 427:254–260. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang NQ, Zhang J, Tang QY, Guo JM and Wang
GM: miRNA-1297 induces cell proliferation by targeting phosphatase
and tensin homolog in testicular germ cell tumor cells. Asian Pac J
Cancer Prev. 15:6243–6246. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu C, Liu Z, Li X, Tang X, He J and Lu S:
MicroRNA-1297 contributes to tumor growth of human breast cancer by
targeting PTEN/PI3K/AKT signaling. Oncol Rep. 38:2435–2443. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Svoronos AA, Engelman DM and Slack FJ:
OncomiR or tumor suppressor? The duplicity of microRNAs in cancer.
Cancer Res. 76:3666–3670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu J, Ye L, Li Q, Wu X, Wang B, Ouyang Y,
Yuan Z, Li J and Lin C: Synaptopodin-2 suppresses metastasis of
triple-negative breast cancer via inhibition of YAP/TAZ activity. J
Pathol. 244:71–83. 2018. View Article : Google Scholar
|
|
46
|
Yu FX, Zhao B and Guan KL: Hippo pathway
in organ size control, tissue homeostasis, and cancer. Cell.
163:811–828. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Park JH, Shin JE and Park HW: The role of
hippo pathway in cancer stem cell biology. Mol Cells. 41:83–92.
2018.PubMed/NCBI
|
|
48
|
Ferraiuolo M, Verduci L, Blandino G and
Strano S: Mutant p53 protein and the hippo transducers YAP and TAZ:
A critical oncogenic node in human cancers. Int J Mol Sci. 18:pii:
E961. 2017.PubMed/NCBI
|
